New findings on inhibitor development: from registries to clinical studies-Reference-Cited by-同舟云学术

New findings on inhibitor development: from registries to clinical studies

Published:2016-12-19 Issue: Volume:23 Page:4-13
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Peyvandi F.¹,Ettingshausen C. E.²,Goudemand J.³,Jiménez-Yuste V.⁴,Santagostino E.¹,Makris M.⁵

Affiliation:

1. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center; Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico and Department of Pathophysiology and Transplantation; Università degli Studi di Milano; Milan Italy

2. HZRM - Haemophilia Centre Rhein Main; Frankfurt-Mörfelden Germany

3. School of Medicine; University of Lille; Lille France

4. Department of Haematology; Autónoma University Madrid and La Paz University Hospital; Madrid Spain

5. Sheffield Haemophilia and Thrombosis Centre; Royal Hallamshire Hospital; Sheffield United Kingdom

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13137/fullpdf

Reference45 articles.

1. Epidemiological aspects of inhibitor development redefine the clinical importance of inhibitors;Berg;Haemophilia,2014

2. The epidemiology of inhibitors in haemophilia A: a systematic review;Wight;Haemophilia,2003

3. Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A;Goudemand;Blood,2006

4. Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A;Chalmers;Haemophilia,2007

5. Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review;Iorio;J Thromb Haemost,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?;Journal of Thrombosis and Haemostasis;2023-11

2. Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study;Blood;2023-04-20

3. First observation of inhibitor development against efmoroctocog alfa in France;Transfusion and Apheresis Science;2021-08

5. Assessment of self‐/parent‐reported quality of life in Japanese children with haemophilia using the Japanese version of KIDSCREEN‐52;Haemophilia;2020-02-24